We’re continuing our celebration of #MedicalUltrasoundAwarenessMonth with another #TeamLantheus spotlight on our cardiology team! We chatted with Claire Stanford about her collaboration with sonographers and the crucial role they play in our ability to #FindFightFollow heart conditions for patients.?? ?? Read more from Claire below and keep an eye on our social media channels for more #MUAM insights this October!?
关于我们
About us With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.
- 网站
-
https://www.lantheus.com/
Lantheus的外部链接
- 所属行业
- 制药业
- 规模
- 501-1,000 人
- 总部
- Bedford，Massachusetts
- 类型
- 上市公司
- 创立
- 1956
- 领域
- Precision diagnostics、Targeted therapeutics、Radiopharmaceutical oncology、Artificial intelligence solutions、Strategic partnerships和Just-in-time manufacturing
地点
Lantheus员工
动态
-
In just three days, #Lantheus is heading to the European Association of Nuclear Medicine (EANM) 2024 World Leader Meeting in Germany! We’re looking forward to learning about multidisciplinary approaches in #nuclearmedicine and sharing insights about the value of #radiopharmaceuticals in patient care.? ? Download the program here: https://bit.ly/3TsKqP5?? ? #LantheusRadiopharma #FindFightFollow?
-
#TeamLantheus is gearing up in preparation for the American Heart Association’s #BostonHeartWalk! On Saturday, October 26th, we’ll be encouraging others to walk to raise awareness for #cardiovasculardisease and make a difference in the lives of patients.?? Join us: https://bit.ly/3MGKdUG? Learn more: https://bit.ly/3zzGUvD?? ? #FindFightFollow
I Walk To Save Lives | Heart Walk
https://www.youtube.com/
-
We are excited to partner with Perceptive Inc. and Endpoints News to bring this important roundtable discussion on?FAP-targeted PET to life on November 7th! Register here: https://bit.ly/3A06J87 ?
Fibroblast Activation Protein (FAP) is a game-changer in tumor imaging, targeting and fibrotic disease evaluation. Learn how FAP-targeted PET is offering new insights into both cancer and fibrosis in our roundtable on November 7. Our distinguished panelists John Babich, Jeremie Calais, Ken Herrmann, and Sherly Mosessian will: o??Explore the dual utility of FAP as a biomarker for oncology and fibrotic diseases. o??Review the advantages of FAP-targeted imaging and how it complements FDG-PET. o??Discuss the theranostic applications of FAP inhibitors. Register Now: https://lnkd.in/ea5kDvwg
-
-
Happy Thanksgiving to the members of #TeamLantheus in Canada! We’re thankful for their dedication to #FindFightFollow disease to deliver better patient outcomes in Canada and beyond.?? ? #OneLantheus?
-
-
Congratulations to our partners at EXINI Diagnostics?on contributing #artificialintelligence insights to the Thera4Care project! This European initiative combines diagnostics and therapies to personalize treatments, aligning with our commitment to #FindFightFollow cancer and other diseases to deliver better patient outcomes. We are excited to see Exini improve cancer care through #AI, which can help providers make data-driven decisions that enhance therapeutic precision and decrease treatment side effects for patients.? ? #Thera4Care
?? EXINI is proud to join the Thera4Care project! ?? We’re part of a European initiative that’s set to revolutionize the use of theranostics and to broaden patient access in Europe – a groundbreaking method that combines diagnostics with targeted therapies for personalized treatment. Our AI expertise will enhance imaging technologies and help tailor cancer treatment protocols,, driving better outcomes for patients and advancing precision oncology. Key goals of Thera4Care: ?? Strengthen the manufacturing and supply chain of radiotheranostics ?? Develop advanced cancer models to test these therapies in the lab. ?? Create frameworks for phase 1 clinical trials ?? Enhance clinical outcomes through AI-based imaging and personalized dosing protocols. Learn more about our role in this innovative project on our website (see link in the comments) #Thera4Care #AIinHealthcare #EXINI
-
-
Join us in welcoming Alexandra Cole, our Learning & Development co-op, to Lantheus' #CoOpCorner! Pursuing a master’s degree in organizational leadership at Northeastern University, Allie holds a B.S. in Business Entrepreneurship with a Minor in Design Studies from Arizona State University. Her experience aligns perfectly with our goals of organizing professional development events, supporting career planning, and fostering growth within our co-op community, showcasing her commitment to #LearnAdaptWin. Outside of work and studies, Allie has a background in comedic arts, having led Sketch Comedy and Improv teams at ASU, and is an experienced graphic designer specializing in branding and film poster design. Welcome aboard, Allie! We’re excited to have you and look forward to your many contributions at #Lantheus.
-
It’s #WorldMentalHealthDay and this year’s theme is “It is Time to Prioritize Mental Health in the Workplace.”?? ? Today, we checked in with our Chief Administrative Officer Dan Niedzwiecki to learn more about the importance of breaking the stigma associated with mental illness. As part of #TeamLantheus, we encourage all employees to #BeTheirBest, including taking care of their emotional and mental well-being.????? ? Learn more from the World Federation for Mental Health: https://bit.ly/4e6CLy2?? ? #WMHD2024? #WorkplaceMentalHealth #PrioritizeMentalHealthintheWorkplace
-
October is #MedicalUltrasoundAwarenessMonth! At #Lantheus, we value the role that sonographers play in our Purpose to #FindFightFollow disease. Their commitment to our innovative #radiodiagnostic tools helps us #GoFurther for patients.?? ? Hear from Golnar H., a member of our cardiology team, about her experience both as a sonographer & working with sonographers! ?? Stay tuned this #MUAM to hear from more of our team.
-
Last week, #TeamLantheus had the pleasure of attending the American Society for Radiation Oncology (ASTRO) Annual Meeting in D.C. and learning more about innovative research in #radiationoncology, including PSMA PET imaging for #prostatecancer. Thank you to our team in attendance and to the speakers who shared their insights!? ? #ASTRO24 #LeadingRadiopharma?
-